Author

Kathleen Shangraw

Observed name: Shangraw, Kathleen

Observed institutions: Campbell University, Mayo Clinic, Oregon Health & Science University, University of Utah, Portland VA Medical Center, VA Portland Health Care System, University of Utah Health Care

ORCID: 0000-0001-6399-5904

Observed ORCID: 0000-0001-6399-5904

OpenAlex ID: A5019840528

Prolonged transcranial magnetic stimulation in a pregnant patient with treatment-resistant depression: a case report

2024 · Rana Jawish, Marcela Smid, et al. · Journal of Medical Case Reports · 6

Medical, Psychiatric, and Sociodemographic Predictors of Clozapine Initiation at an Academic Medical Center

2024 · Kathleen Shangraw, Christian Schmutz, et al. · Psychiatric Research and Clinical Practice · 4

Enlarged perivascular spaces are not associated with vascular co-morbidities, clinical outcomes, and brain volumes in people with secondary progressive multiple sclerosis

2020 · Lindsey Wooliscroft, Erin Boespflug, et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical · 4

Effect of Vascular Comorbidity on Visual and Disability Outcomes in a Secondary Progressive Multiple Sclerosis Clinical Trial Cohort

2022 · Kathleen Shangraw, Charles F. Murchison, et al. · International Journal of MS Care · 2

Interest in Transcranial Magnetic Stimulation Therapy for Treatment of Depression and Substance Use Disorder Among Peripartum Individuals

2025 · Rana Jawish, Kathleen Shangraw, et al. · Journal of Addiction Medicine

Associations Between Vascular Comorbidity, Visual Acuity and Optical Coherence Tomography in Secondary Progressive Multiple Sclerosis (1728)

2020 · Kathleen Shangraw, Chad Murchison, et al. · Neurology

Works count: 8

Citation count: 16

H-index: 3

I10-index: